Clinical Trial for Eosinophilic Asthma

Eosinophilic asthma is a rare and severe form of asthma driven by high levels of eosinophils—a type of white blood cell that can cause inflammation in the lungs. This condition often leads to frequent asthma attacks, difficulty breathing, and poor response to standard asthma treatments. People living with eosinophilic asthma may experience persistent eosinophilic asthma symptoms despite using inhalers or steroids.

This study aims to compare the effectiveness of switching to a new treatment versus continuing the current treatment for people with severe asthma that has an eosinophilic component. The focus is on whether the new treatment can help reduce the number of serious asthma flare-ups, or exacerbations, as compared to sticking with the current treatment. Throughout the study, all participants will continue their usual asthma care alongside the study treatment. The goal is to determine if switching treatments offers similar or better results in preventing asthma attacks.